Physicians’ knowledge, practices, and attitudes on bone health management in breast and gynecological cancer patients

Background Osteoporosis is a systemic disease characterized by low bone mass and structural deterioration, increasing fracture risk. Cancer therapies, including chemotherapy and endocrine treatments (ET), may negatively affect bone health. Aims To assess clinicians’ knowledge and management practices regarding osteoporosis in patients receiving breast and gynecological cancer treatments at a large oncology institution. Methods Between January and April 2025, an anonymous 24-item survey was administered to physicians involved in managing patients with breast and gynecological cancers at the European Institute of Oncology. The survey focused on treatment-induced menopause and hypoestrogenism, including surgical ovarian ablation and pharmacological ovarian suppression. Both naturally postmenopausal women and premenopausal women experiencing treatment-induced menopause were included. Results The response rate was 73.5% (86/117). Among respondents, 93% routinely prescribe baseline bone densitometry (DXA) for patients with treatment-induced menopause, whereas only 6% refer patients to a specialist. Although 83.5% assess vitamin D levels and 91.5% prescribe supplementation when indicated, only 20.4% regularly initiate antiresorptive therapy (AT) at the start of ET. Decisions regarding AT or specialist referral are mainly based on DXA results (75%). Moreover, 46% believe AT should be offered to all postmenopausal patients, regardless of ET type. Discussion The survey highlights a substantial gap between guideline recommendations and clinical practice, even within a leading oncology center. Conclusions Targeted education and training are needed to improve clinicians’ knowledge and optimize bone health management in cancer survivorship care.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-18
DOI
https://doi.org/10.21203/rs.3.rs-11511759/v1
Primary Topic
Bone health and osteoporosis research
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Physicians’ knowledge, practices, and attitudes on bone health management in breast and gynecological cancer patients

Giuseppe Curigliano, Viviana Enrica Galimberti, Dario Trapani, Elisabetta Munzone et al.
3 links
Research Square
Bone health and osteoporosis research
preprint

Physicians’ knowledge, practices, and attitudes on bone health management in breast and gynecological cancer patients

Giuseppe Curigliano, Viviana Enrica Galimberti, Dario Trapani, Elisabetta Munzone, Nadia Bianco, Marco Angelo Colleoni, Maria Luisa Brandi, Claudia Sangalli, Dorella Franchi, Silvia Martella, Carmine Valenza, Monica Milano, Cecilia Mariani, Giulia Malvezzi, Marco Francesco Manzoni
preprint en

Abstract

Background Osteoporosis is a systemic disease characterized by low bone mass and structural deterioration, increasing fracture risk. Cancer therapies, including chemotherapy and endocrine treatments (ET), may negatively affect bone health. Aims To assess clinicians’ knowledge and management practices regarding osteoporosis in patients receiving breast and gynecological cancer treatments at a large oncology institution. Methods Between January and April 2025, an anonymous 24-item survey was administered to physicians involved in managing patients with breast and gynecological cancers at the European Institute of Oncology. The survey focused on treatment-induced menopause and hypoestrogenism, including surgical ovarian ablation and pharmacological ovarian suppression. Both naturally postmenopausal women and premenopausal women experiencing treatment-induced menopause were included. Results The response rate was 73.5% (86/117). Among respondents, 93% routinely prescribe baseline bone densitometry (DXA) for patients with treatment-induced menopause, whereas only 6% refer patients to a specialist. Although 83.5% assess vitamin D levels and 91.5% prescribe supplementation when indicated, only 20.4% regularly initiate antiresorptive therapy (AT) at the start of ET. Decisions regarding AT or specialist referral are mainly based on DXA results (75%). Moreover, 46% believe AT should be offered to all postmenopausal patients, regardless of ET type. Discussion The survey highlights a substantial gap between guideline recommendations and clinical practice, even within a leading oncology center. Conclusions Targeted education and training are needed to improve clinicians’ knowledge and optimize bone health management in cancer survivorship care.

Research Square
European Institute of Oncology (IT)
Good health and well-being
Bone health and osteoporosis research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon